Court in Kenya Suspends Plans for U.S. Ebola Quarantine Unit
The order came after U.S. officials said that a 50-bed facility was being established in the African country to house American citizens expo...
Suit Says Black Infants Were Subjected to Experimental Vaccine Without Consent
The babies were part of a vaccine trial for a respiratory virus in the 1960s and died shortly after. Their families said they had been unawa...
Genetic Scores are Booming. But Will Anti-Discrimination Laws Cover Your DNA?
As predictive medicine advances, legal scholars warn that decades-old federal guidelines could set up a potential clash between your genes a...
KFF’s Chief Executive to Retire
Drew Altman, who transformed KFF from a little-known family foundation to a major source of U.S. health policy research, will step down at t...
The Viruses Causing New Outbreaks Are Much Less Familiar to Science
The types of Ebola and hantavirus panicking officials are very different from the species identified decades ago, raising new questions abou...
Trump Administration to Send Americans Exposed to Ebola to Kenya
In past outbreaks, Americans exposed to the virus were sent home to be treated in state-of-the-art facilities. The Trump administration has ...
Eli Lilly to Buy 3 Vaccine Developers
The drugmaker said it would spend up to $4 billion to acquire small companies exploring vaccines for shingles, Epstein-Barr virus and other ...
A Powerful H.I.V. Drug Lands in Zambia. But Will It Reach Those Who Need It?
Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health system has been ...
One-and-Done Heart Disease Prevention? Scientists Show It May Be Possible.
A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point to something “...
Caught Flat-Footed, a City Races to Catch Up With Ebola
The deadly virus has spread alarmingly in Congo for months. Only now is the response taking shape. from NYT > Health https://ift.tt/EgO...
Subscribe to:
Posts
(
Atom
)
